The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Anderson Karen M. since 2020.
This trader's CIK number is 1762176.
At the time of last reporting, Anderson Karen M. was the Chief People Officer of Centessa Pharmaceuticals Plc. (stock ticker symbol CNTA).
Also see all insider trading activities at Centessa Pharmaceuticals Plc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | MIME | 0 | $0 | 0 | $0 | 17,298 | $0 |
2021 | MIME | 0 | $0 | 38,014 | $2,251,806 | 44,560 | $1,188,544 |
2020 | MIME | 0 | $0 | 0 | $0 | 8,730 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | CNTA | 0 | $0 | 37,426 | $698,059 | 30,955 | $124,129 |
2024 | CNTA | 0 | $0 | 67,660 | $894,402 | 61,500 | $240,374 |
2. Centessa Pharmaceuticals Plc (CNTA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-04-01 | MIME | Option Ex | 8,632 | .00 | 0 |
2022-02-01 | MIME | Option Ex | 8,666 | .00 | 0 |
2021-11-01 | MIME | Sale | 7,812 | 75.82 | 592,282 |
2021-11-01 | MIME | Option Ex | 7,812 | 40.00 | 312,480 |
2021-10-01 | MIME | Option Ex | 1,859 | 33.38 | 62,053 |
2021-10-01 | MIME | Sale | 1,859 | 64.72 | 120,323 |
2021-08-10 | MIME | Option Ex | 17,483 | 36.69 | 641,451 |
2021-08-10 | MIME | Sale | 17,483 | 58.80 | 1,027,912 |
2021-06-09 | MIME | Sale | 4,314 | 51.99 | 224,284 |
2021-06-09 | MIME | Option Ex | 4,314 | 40.00 | 172,560 |
2021-04-05 | MIME | Sale | 2,248 | 40.75 | 91,606 |
2021-04-01 | MIME | Option Ex | 4,496 | .00 | 0 |
2021-02-01 | MIME | Option Ex | 8,596 | .00 | 0 |
2021-02-02 | MIME | Sale | 4,298 | 45.46 | 195,399 |
2020-02-01 | MIME | Option Ex | 4,365 | .00 | 0 |
2020-02-02 | MIME | Option Ex | 4,365 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-07 | CNTA | Option Ex | 30,526 | 4.01 | 122,409 |
2025-02-07 | CNTA | Sale | 30,526 | 19.03 | 580,787 |
2025-02-10 | CNTA | Option Ex | 429 | 4.01 | 1,720 |
2025-02-10 | CNTA | Sale | 429 | 18.99 | 8,146 |
2025-02-03 | CNTA | Sale | 6,471 | 16.86 | 109,126 |
2024-12-17 | CNTA | Sale | 10,624 | 17.32 | 184,039 |
2024-12-17 | CNTA | Option Ex | 10,624 | 3.85 | 40,902 |
2024-12-13 | CNTA | Sale | 5,876 | 17.01 | 99,974 |
2024-12-13 | CNTA | Option Ex | 5,876 | 3.85 | 22,622 |
2024-03-25 | CNTA | Option Ex | 45,000 | 3.93 | 176,850 |
2024-03-25 | CNTA | Sale | 51,160 | 11.93 | 610,389 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anderson Karen M. (Chief People Officer of Centessa Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.